Patents by Inventor Juha Kirveskari

Juha Kirveskari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230323478
    Abstract: The present invention provides a nucleic acid amplification based method for detecting a hypervirulent Clostridium difficile strain in a biological sample. The present invention is based on the use of oligonucleotide primers and probes specific to negative and positive markers in hypervirulent Clostridium difficile genome.
    Type: Application
    Filed: December 22, 2022
    Publication date: October 12, 2023
    Applicant: Mobidiag Ltd
    Inventors: Juha Kirveskari, Jaakko Kurkela
  • Patent number: 11566294
    Abstract: The present invention provides a nucleic acid amplification based method for detecting a hypervirulent Clostridium difficile strain in a biological sample. The present invention is based on the use of oligonucleotide primers and probes specific to negative and positive markers in hypervirulent Clostridium difficile genome.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: January 31, 2023
    Assignee: Mobidiag Ltd.
    Inventors: Juha Kirveskari, Jaakko Kurkela
  • Publication number: 20230028364
    Abstract: This invention relates to the field of detection of intestinal parasites from patient, food or environmental samples, preferably from a stool sample. Particularly, the present invention provides a polymerase chain reaction (PCR) based assay method for detection of intestinal parasite infection, particularly the infection of parasite species selected from a group consisting of Hymenolepis nana, Hymenolepis diminuta, Fasciolopsis buski, Encephalitozoon spp. (such as E. intestinalis, E. cuniculi and E. hellem), Enterocytozoon bieneusi, Enterobius vermicularis, Diphyllobothrium latum, Diphyllobothrium nihonkaiense, Schistosoma mansoni, Blastocystis hominis, Ancylostoma duodenale and liver worms, such as Clonorchis sinensis, Opisthorchis spp., and Metorchis spp. The present invention further provides materials such as primers, primer pairs and probes for use in the method of the invention.
    Type: Application
    Filed: November 16, 2020
    Publication date: January 26, 2023
    Inventors: Juha Kirveskari, Pasi Piiparinen, Jari Hirvonen, Juha Saharinen
  • Patent number: 10724106
    Abstract: This invention relates to the field of detection of diarrhoea causing pathogens from patient, food or environmental samples. Particularly, the present invention provides a polymerase chain reaction (PCR) based assay method for detection of diarrhoea causing pathogens. The present invention further provides materials such as primers, primer pairs and probes for use in the method of the invention. Preferably, the method of the invention is a multiplex real-time PCR (RT-PCR) assay for rapid determination of clinically important pathogens related to traveller's diarrhoea.
    Type: Grant
    Filed: June 27, 2013
    Date of Patent: July 28, 2020
    Assignee: MOBIDIAG OY
    Inventors: Jenni Antikainen, Juha Kirveskari
  • Publication number: 20190345540
    Abstract: The present invention provides a nucleic acid amplification based method for detecting a hypervirulent Clostridium difficile strain in a biological sample. The present invention is based on the use of oligonucleotide primers and probes specific to negative and positive markers in hypervirulent Clostridium difficile genome.
    Type: Application
    Filed: December 18, 2015
    Publication date: November 14, 2019
    Inventors: Juha Kirveskari, Jaakko Kurkela
  • Patent number: 9868995
    Abstract: The present invention provides a PCR based method for detecting chronic gastritis causing bacterium, namely Helicobacter pylori, in a stool sample. The present invention is based on the use of oligonucleotide primers and probes specific to H. pylori 23S rRNA gene.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: January 16, 2018
    Assignee: AMPLIDIAG OY
    Inventors: Juha Kirveskari, Hilpi Rautelin
  • Patent number: 9593381
    Abstract: The present invention relates to a method and kit for detecting carbapenemase resistance genes causing carbapenem resistance in bacteria. The invention provides oligonucleotide primers, which can be used in the detection. The method can be used to detect OXA-48, SME, GIM-1, VIM 1-22, SPM, GES 1-10, KPC 1-7, IMI 1-3/NMC-A, IMP 1-24 within a single reaction and OXA-23 group, OXA-24 group, OXA-51 group with ISabal promoter, OXA-55, OXA-58, OXA-60, OXA-62, CMY 1, -10, -11 SFC-1, NDM-1, and SIM-1 within another single reaction.
    Type: Grant
    Filed: November 15, 2011
    Date of Patent: March 14, 2017
    Assignee: Amplidiag OY
    Inventors: Juha Kirveskari, Suvi Koskela
  • Publication number: 20160017406
    Abstract: The present invention provides a PCR based method for detecting chronic gastritis causing bacterium, namely Helicobacter pylori, in a stool sample. The present invention is based on the use of oligonucleotide primers and probes specific to H. pylori 23S rRNA gene.
    Type: Application
    Filed: December 5, 2013
    Publication date: January 21, 2016
    Applicant: AMPLIDIAG OY
    Inventors: Juha KIRVESKARI, Hilpi RAUTELIN
  • Publication number: 20150299774
    Abstract: This invention relates to the field of detection of diarrhoea causing pathogens from patient, food or environmental samples. Particularly, the present invention provides a polymerase chain reaction (PCR) based assay method for detection of diarrhoea causing pathogens. The present invention further provides materials such as primers, primer pairs and probes for use in the method of the invention. Preferably, the method of the invention is a multiplex real-time PCR (RT-PCR) assay for rapid determination of clinically important pathogens related to traveller's diarrhoea.
    Type: Application
    Filed: June 27, 2013
    Publication date: October 22, 2015
    Applicant: MOBIDIAG OY
    Inventors: Jenni Antikainen, Juha Kirveskari
  • Publication number: 20120129180
    Abstract: The present invention relates to a method and kit for detecting carbapenemase resistance genes causing carbapenem resistance in bacteria. The invention provides oligonucleotide primers, which can be used in the detection. The method can be used to detect OXA-48, SME, GIM-1, VIM 1-22, SPM, GES 1-10, KPC 1-7, IMI 1-3/NMC-A, IMP 1-24 within a single reaction and OXA-23 group, OXA-24 group, OXA-51 group with ISabal promoter, OXA-55, OXA-58, OXA-60, OXA-62, CMY 1, -10, -11 SFC-1, NDM-1, and SIM-1 within another single reaction.
    Type: Application
    Filed: November 15, 2011
    Publication date: May 24, 2012
    Inventors: Juha Kirveskari, Suvi Koskela